Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 643

1.

Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial.

Frei H, Everts R, von Ammon K, Kaufmann F, Walther D, Schmitz SF, Collenberg M, Steinlin M, Lim C, Thurneysen A.

Homeopathy. 2007 Jan;96(1):35-41.

PMID:
17227746
[PubMed - indexed for MEDLINE]
2.

Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial.

Frei H, Everts R, von Ammon K, Kaufmann F, Walther D, Hsu-Schmitz SF, Collenberg M, Fuhrer K, Hassink R, Steinlin M, Thurneysen A.

Eur J Pediatr. 2005 Dec;164(12):758-67. Epub 2005 Jul 27.

PMID:
16047154
[PubMed - indexed for MEDLINE]
3.

Homeopathy for attention-deficit/hyperactivity disorder: a pilot randomized-controlled trial.

Jacobs J, Williams AL, Girard C, Njike VY, Katz D.

J Altern Complement Med. 2005 Oct;11(5):799-806.

PMID:
16296913
[PubMed - indexed for MEDLINE]
4.

Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting.

Frei H, Thurneysen A.

Br Homeopath J. 2001 Oct;90(4):183-8.

PMID:
11680802
[PubMed - indexed for MEDLINE]
5.

The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice.

Katz T, Fisher P, Katz A, Davidson J, Feder G.

Homeopathy. 2005 Jul;94(3):145-52.

PMID:
16060200
[PubMed - indexed for MEDLINE]
6.

Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.

Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group.

Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. doi: 10.1016/j.euroneuro.2009.07.008. Epub 2009 Aug 28.

PMID:
19716683
[PubMed - indexed for MEDLINE]
7.

A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder.

Bonne O, Shemer Y, Gorali Y, Katz M, Shalev AY.

J Clin Psychiatry. 2003 Mar;64(3):282-7.

PMID:
12716269
[PubMed - indexed for MEDLINE]
8.

Individual differences in response to randomly assigned active individualized homeopathic and placebo treatment in fibromyalgia: implications of a double-blinded optional crossover design.

Bell IR, Lewis DA 2nd, Brooks AJ, Schwartz GE, Lewis SE, Caspi O, Cunningham V, Baldwin CM.

J Altern Complement Med. 2004 Apr;10(2):269-83.

PMID:
15165408
[PubMed - indexed for MEDLINE]
9.

Evaluation of specific and non-specific effects in homeopathy: feasibility study for a randomised trial.

Fisher P, McCarney R, Hasford C, Vickers A.

Homeopathy. 2006 Oct;95(4):215-22.

PMID:
17015192
[PubMed - indexed for MEDLINE]
10.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
[PubMed - indexed for MEDLINE]
11.

Efficacy of a complex homeopathic medication (Sinfrontal) in patients with acute maxillary sinusitis: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial.

Zabolotnyi DI, Kneis KC, Richardson A, Rettenberger R, Heger M, Kaszkin-Bettag M, Heger PW.

Explore (NY). 2007 Mar-Apr;3(2):98-109.

PMID:
17362845
[PubMed - indexed for MEDLINE]
12.

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N; SPD503 Study Group.

Pediatrics. 2008 Jan;121(1):e73-84. doi: 10.1542/peds.2006-3695.

PMID:
18166547
[PubMed - indexed for MEDLINE]
Free Article
13.

Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.

Biederman J, Pliszka SR.

J Pediatr. 2008 Mar;152(3):394-9. doi: 10.1016/j.jpeds.2007.07.052. Epub 2007 Oct 24.

PMID:
18280848
[PubMed - indexed for MEDLINE]
14.

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder.

Montoya A, Hervas A, Cardo E, Artigas J, Mardomingo MJ, Alda JA, Gastaminza X, García-Polavieja MJ, Gilaberte I, Escobar R.

Curr Med Res Opin. 2009 Nov;25(11):2745-54. doi: 10.1185/03007990903316152.

PMID:
19785510
[PubMed - indexed for MEDLINE]
15.

Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial.

Weber W, Vander Stoep A, McCarty RL, Weiss NS, Biederman J, McClellan J.

JAMA. 2008 Jun 11;299(22):2633-41. doi: 10.1001/jama.299.22.2633.

PMID:
18544723
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Open-label use of placebos in the treatment of ADHD: a pilot study.

Sandler AD, Bodfish JW.

Child Care Health Dev. 2008 Jan;34(1):104-10. doi: 10.1111/j.1365-2214.2007.00797.x.

PMID:
18171451
[PubMed - indexed for MEDLINE]
17.

Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.

Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.

J Clin Psychiatry. 2007 Feb;68(2):268-77.

PMID:
17335326
[PubMed - indexed for MEDLINE]
18.

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

Prasad S, Harpin V, Poole L, Zeitlin H, Jamdar S, Puvanendran K; SUNBEAM Study Group.

Curr Med Res Opin. 2007 Feb;23(2):379-94.

PMID:
17288692
[PubMed - indexed for MEDLINE]
19.

Double-blind, placebo-controlled homeopathic pathogenetic trials: symptom collection and analysis.

Dominici G, Bellavite P, di Stanislao C, Gulia P, Pitari G.

Homeopathy. 2006 Jul;95(3):123-30.

PMID:
16815514
[PubMed - indexed for MEDLINE]
20.

Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.

Boellner SW, Earl CQ, Arora S.

Curr Med Res Opin. 2006 Dec;22(12):2457-65.

PMID:
17257460
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk